Track Phio Pharmaceuticals's total current liabilities ($890K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Phio Pharmaceuticals (PHIO) currently reports a total current liabilities of $890K as of September 2026. That compares with $520K in the prior-year period — up 71.7% year over year. Use the charts on this page to explore Phio Pharmaceuticals's total current liabilities history and peer comparisons.
Phio Pharmaceuticals's total current liabilities increased from $520K to $890K — a 71.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Phio Pharmaceuticals reported $890K in total current liabilities as of September 2026. That compares with $520K in the prior-year period — up 71.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $890K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phio Pharmaceuticals, and consider following PHIO for alerts when major investors trade the stock.
Phio Pharmaceuticals is classified in the Healthcare sector. On total current liabilities, it currently shows $890K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHIO with unrelated industries.